{"id":"https://openalex.org/W3131464005","doi":"https://doi.org/10.1021/acsmedchemlett.0c00660","title":"Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1","display_name":"Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1","publication_year":2021,"publication_date":"2021-02-19","ids":{"openalex":"https://openalex.org/W3131464005","doi":"https://doi.org/10.1021/acsmedchemlett.0c00660","mag":"3131464005","pmid":"https://pubmed.ncbi.nlm.nih.gov/33732413","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7957935"},"language":"en","primary_location":{"id":"doi:10.1021/acsmedchemlett.0c00660","doi":"https://doi.org/10.1021/acsmedchemlett.0c00660","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acsmedchemlett.0c00660","pdf_url":"https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.0c00660","source":{"id":"https://openalex.org/S191852912","display_name":"ACS Medicinal Chemistry Letters","issn_l":"1948-5875","issn":["1948-5875"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.0c00660","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041084487","display_name":"Andrew P. Degnan","orcid":"https://orcid.org/0000-0001-6210-9501","observed_orcids":["https://orcid.org/0000-0001-6210-9501"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Andrew P. Degnan","raw_affiliation_strings":["Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States"],"raw_orcid":"https://orcid.org/0000-0001-6210-9501","affiliations":[{"raw_affiliation_string":"Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049516599","display_name":"Godwin K. Kumi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Godwin K. Kumi","raw_affiliation_strings":["Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041670546","display_name":"Christopher W. Allard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher W. Allard","raw_affiliation_strings":["Research & Development, Bristol Myers Squibb Company, Wallingford, Connecticut 06492, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Bristol Myers Squibb Company, Wallingford, Connecticut 06492, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043085287","display_name":"Erika M. V. Araujo","orcid":"https://orcid.org/0009-0007-8781-9375","observed_orcids":["https://orcid.org/0009-0007-8781-9375"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erika V. Araujo","raw_affiliation_strings":["Research & Development, Bristol Myers Squibb Company, Wallingford, Connecticut 06492, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Bristol Myers Squibb Company, Wallingford, Connecticut 06492, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113446756","display_name":"Walter L. Johnson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Walter L. Johnson","raw_affiliation_strings":["Research & Development, Bristol Myers Squibb Company, Redwood City, California 94063, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Bristol Myers Squibb Company, Redwood City, California 94063, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103219610","display_name":"Kurt Zimmermann","orcid":"https://orcid.org/0009-0003-3420-9451","observed_orcids":["https://orcid.org/0009-0003-3420-9451"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kurt Zimmermann","raw_affiliation_strings":["Research & Development, Bristol Myers Squibb Company, Wallingford, Connecticut 06492, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Bristol Myers Squibb Company, Wallingford, Connecticut 06492, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016151028","display_name":"Bradley C. Pearce","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bradley C. Pearce","raw_affiliation_strings":["Research & Development, Bristol Myers Squibb Company, Wallingford, Connecticut 06492, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Bristol Myers Squibb Company, Wallingford, Connecticut 06492, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054958759","display_name":"S. Sheriff","orcid":"https://orcid.org/0000-0001-6010-6534","observed_orcids":["https://orcid.org/0000-0001-6010-6534"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Sheriff","raw_affiliation_strings":["Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033131615","display_name":"Alan S. Futran","orcid":"https://orcid.org/0000-0002-2132-312X","observed_orcids":["https://orcid.org/0000-0002-2132-312X"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan Futran","raw_affiliation_strings":["Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112276493","display_name":"Xin Li","orcid":"https://orcid.org/0000-0002-3778-5193","observed_orcids":["https://orcid.org/0000-0002-3778-5193"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xin Li","raw_affiliation_strings":["Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083181975","display_name":"Gregory A. Locke","orcid":"https://orcid.org/0009-0007-7880-2061","observed_orcids":["https://orcid.org/0009-0007-7880-2061"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory A. Locke","raw_affiliation_strings":["Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Dan You","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dan You","raw_affiliation_strings":["Research & Development, Bristol Myers Squibb Company, 100 Binney Street, Cambridge, Massachusetts 02142, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Bristol Myers Squibb Company, 100 Binney Street, Cambridge, Massachusetts 02142, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":null,"display_name":"John Morrison","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Morrison","raw_affiliation_strings":["Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009433459","display_name":"Karen E. Parrish","orcid":"https://orcid.org/0000-0001-8324-5553","observed_orcids":["https://orcid.org/0000-0001-8324-5553"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen E. Parrish","raw_affiliation_strings":["Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020627066","display_name":"Caitlyn Stromko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caitlyn Stromko","raw_affiliation_strings":["Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111598591","display_name":"Anwar Murtaza","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anwar Murtaza","raw_affiliation_strings":["Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101697111","display_name":"Jinqi Liu","orcid":"https://orcid.org/0000-0002-0094-9801","observed_orcids":["https://orcid.org/0000-0002-0094-9801"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jinqi Liu","raw_affiliation_strings":["Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075919164","display_name":"Benjamin M. Johnson","orcid":"https://orcid.org/0000-0001-5277-4743","observed_orcids":["https://orcid.org/0000-0001-5277-4743"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin M. Johnson","raw_affiliation_strings":["Research & Development, Bristol Myers Squibb Company, 100 Binney Street, Cambridge, Massachusetts 02142, United States"],"raw_orcid":"https://orcid.org/0000-0001-5277-4743","affiliations":[{"raw_affiliation_string":"Research & Development, Bristol Myers Squibb Company, 100 Binney Street, Cambridge, Massachusetts 02142, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064763949","display_name":"Gregory D. Vite","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory D. Vite","raw_affiliation_strings":["Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Bristol Myers Squibb Company, Princeton, New Jersey 08543, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109973671","display_name":"Mark D. Wittman","orcid":"https://orcid.org/0009-0000-4951-3825","observed_orcids":["https://orcid.org/0009-0000-4951-3825"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark D. Wittman","raw_affiliation_strings":["Research & Development, Bristol Myers Squibb Company, 100 Binney Street, Cambridge, Massachusetts 02142, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development, Bristol Myers Squibb Company, 100 Binney Street, Cambridge, Massachusetts 02142, United States","institution_ids":["https://openalex.org/I4210091812"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5041084487"],"corresponding_institution_ids":["https://openalex.org/I4210091812"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":{"value":5000,"currency":"USD","value_usd":5000},"fwci":4.1016,"has_fulltext":false,"cited_by_count":70,"citation_normalized_percentile":{"value":0.96547418,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"12","issue":"3","first_page":"443","last_page":"450"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7172999978065491,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7172999978065491,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.12549999356269836,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.06759999692440033,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hpk1","display_name":"HPK1","score":0.9610000252723694},{"id":"https://openalex.org/keywords/hpk1-inhibitors","display_name":"HPK1 inhibitors","score":0.8849999904632568},{"id":"https://openalex.org/keywords/t-cell-receptor-signaling","display_name":"T cell receptor signaling","score":0.7459999918937683},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.6679999828338623},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.8970000147819519},{"id":"https://openalex.org/keywords/structure-based-drug-design","display_name":"structure-based drug design","score":0.7129999995231628},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.8190000057220459},{"id":"https://openalex.org/keywords/plasma-protein-binding","display_name":"plasma protein binding","score":0.8119999766349792},{"id":"https://openalex.org/keywords/metabolic-stability","display_name":"metabolic stability","score":0.8009999990463257},{"id":"https://openalex.org/keywords/kinase-inhibitor-selectivity","display_name":"kinase selectivity","score":0.5400000214576721}],"concepts":[{"id":"https://openalex.org/C201750760","wikidata":"https://www.wikidata.org/wiki/Q1896218","display_name":"Progenitor cell","level":3,"score":0.5881198048591614},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5565854907035828},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5445225238800049},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4714663326740265},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45979851484298706},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4591256380081177},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.4460179805755615},{"id":"https://openalex.org/C6929976","wikidata":"https://www.wikidata.org/wiki/Q3771881","display_name":"Regulator","level":3,"score":0.431857705116272},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32479023933410645},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.31884026527404785},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3037247657775879},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.2270936667919159},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12524569034576416},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.11348339915275574},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1021/acsmedchemlett.0c00660","doi":"https://doi.org/10.1021/acsmedchemlett.0c00660","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acsmedchemlett.0c00660","pdf_url":"https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.0c00660","source":{"id":"https://openalex.org/S191852912","display_name":"ACS Medicinal Chemistry Letters","issn_l":"1948-5875","issn":["1948-5875"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7957935","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7957935","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Med Chem Lett","raw_type":"Text"},{"id":"pmid:33732413","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33732413","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS medicinal chemistry letters","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1021/acsmedchemlett.0c00660","doi":"https://doi.org/10.1021/acsmedchemlett.0c00660","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acsmedchemlett.0c00660","pdf_url":"https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.0c00660","source":{"id":"https://openalex.org/S191852912","display_name":"ACS Medicinal Chemistry Letters","issn_l":"1948-5875","issn":["1948-5875"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Medicinal Chemistry Letters","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W3131464005.pdf"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W1964370181","https://openalex.org/W2012034410","https://openalex.org/W2051303299","https://openalex.org/W2172368692","https://openalex.org/W2345568581","https://openalex.org/W2755531315","https://openalex.org/W2791483720","https://openalex.org/W2895159427","https://openalex.org/W2902996665","https://openalex.org/W2925294180","https://openalex.org/W2941910861","https://openalex.org/W3117805063","https://openalex.org/W3119209177"],"related_works":["https://openalex.org/W4402623725","https://openalex.org/W4311180003","https://openalex.org/W4402181047","https://openalex.org/W4385304393","https://openalex.org/W4388904350","https://openalex.org/W4391655837","https://openalex.org/W4415687831","https://openalex.org/W4392454652","https://openalex.org/W4362734836","https://openalex.org/W4386192377"],"abstract_inverted_index":{"High":[0],"Resolution":[1],"Image":[2],"Download":[3],"MS":[4],"PowerPoint":[5],"Slide":[6],"While":[7],"the":[8,45,72,78,89,105],"discovery":[9,80],"of":[10,23,48,65,81,85,88,107,113,124,132],"immune":[11,73],"checkpoint":[12],"inhibitors":[13,84],"has":[14],"led":[15,91],"to":[16,30,39,43,70,92],"robust,":[17],"durable":[18],"responses":[19],"in":[20,94,104,115,127],"a":[21,56,62,128],"range":[22],"cancers,":[24],"many":[25],"patients":[26],"do":[27],"not":[28],"respond":[29],"currently":[31],"available":[32],"therapeutics.":[33],"Therefore,":[34],"an":[35,118],"urgent":[36],"need":[37],"exists":[38],"identify":[40],"alternative":[41],"mechanisms":[42],"augment":[44],"immune-mediated":[46],"clearance":[47],"tumors.":[49],"Hematopoetic":[50],"progenitor":[51],"kinase":[52,58],"1":[53],"(HPK1)":[54],"is":[55],"serine-threonine":[57],"that":[59],"acts":[60],"as":[61,83],"negative":[63],"regulator":[64],"T-cell":[66],"receptor":[67],"(TCR)":[68],"signaling,":[69],"dampen":[71],"response.":[74],"Herein":[75],"we":[76],"describe":[77],"structure-based":[79],"isofuranones":[82],"HPK1.":[86],"Optimization":[87],"chemotype":[90],"improvements":[93],"potency,":[95],"selectivity,":[96],"plasma":[97],"protein":[98],"binding,":[99],"and":[100],"metabolic":[101],"stability,":[102],"culminating":[103],"identification":[106],"compound":[108],"24":[109],".":[110],"Oral":[111],"administration":[112],"24,":[114],"combination":[116],"with":[117],"anti-PD1":[119,125],"antibody,":[120],"demonstrated":[121],"robust":[122],"enhancement":[123],"efficacy":[126],"syngeneic":[129],"tumor":[130],"model":[131],"colorectal":[133],"cancer.":[134]},"counts_by_year":[{"year":2026,"cited_by_count":16},{"year":2025,"cited_by_count":17},{"year":2024,"cited_by_count":19},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-03-01T00:00:00"}